Optivise Advisory Services’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.01M Buy
3,799
+109
+3% +$28.8K 0.49% 56
2026
Q2
$937K Buy
3,690
+397
+12% +$92.5K 0.48% 58
2026
Q1
$805K Sell
3,293
-479
-13% -$112K 0.49% 56
2025
Q4
$781K Buy
3,772
+763
+25% +$151K 0.45% 65
2025
Q3
$558K Buy
3,009
+849
+39% +$145K 0.33% 80
2025
Q2
$330K Sell
2,160
-105
-5% -$16.1K 0.17% 123
2025
Q1
$376K Buy
2,265
+169
+8% +$26.4K 0.21% 106
2024
Q4
$303K Buy
2,096
+284
+16% +$44K 0.16% 129
2024
Q3
$294K Sell
1,812
-266
-13% -$42.4K 0.15% 121
2024
Q2
$304K Buy
+2,078
New +$309K 0.16% 126

Other funds holding JNJ

Optivise Advisory Services's JNJ Position: Q3 2026 in Review

Optivise Advisory Services increased its Johnson & Johnson (JNJ) stake by 3% in Q3 2026, buying an estimated $28.8K and bringing the position to 3,799 shares worth $1.01M. The position accounts for 0.49% of the portfolio, ranked #56.

Optivise Advisory Services first reported a position in JNJ in Q2 2024 and has held it in 10 quarters since. 2,986 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Optivise Advisory Services held 3,799 shares of Johnson & Johnson worth $1.01M as of Q3 2026.
  • Optivise Advisory Services bought 109 Johnson & Johnson shares in Q3 2026, an estimated $28.8K.
  • Johnson & Johnson made up 0.49% of Optivise Advisory Services's portfolio in Q3 2026, its #56 holding.
  • Optivise Advisory Services first reported a position in Johnson & Johnson in Q2 2024 and has held it in 10 quarters since.
  • 2,986 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Optivise Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.